CJC/IPA 10mg
High-purity peptide powder in a sealed vial
$49.00
Out of stock
CJC-1295 and Ipamorelin (Research Use Only)
Product Description
CJC-1295, a synthetic growth hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective growth hormone secretagogue (GHS), are peptides designed exclusively for laboratory research. CJC-1295, available with or without a Drug Affinity Complex (DAC), and Ipamorelin are intended for controlled in vitro experiments and preclinical animal studies to investigate growth hormone (GH) signaling pathways. These products are not approved by the FDA for human or veterinary consumption, diagnostic use, or therapeutic applications.
CJC-1295: Available with DAC (extending half-life to approximately 6-8 days in experimental models) or without DAC (half-life approximately 30 minutes). Studied for its interaction with pituitary receptors in research settings.
Ipamorelin: Mimics ghrelin and binds to GHS receptors in experimental models, with a half-life of approximately 2 hours.
Research Applications
In Vitro Experiments: Suitable for cell culture studies examining pituitary receptor activation, GH signaling, or related cellular pathways in controlled laboratory settings.
Preclinical Studies: Appropriate for animal-based research exploring the effects of GHRH or GHS analogs on hormonal signaling under strict experimental conditions.
Biochemical Research: Can be used to analyze peptide-receptor binding, stability, or downstream cellular effects in laboratory environments.
Mechanism of Action (Research Context)
In experimental settings, these peptides may be studied for:
CJC-1295: Interactions with pituitary receptors to explore GH release dynamics in in vitro or preclinical models.
Ipamorelin: Binding to GHS receptors to investigate GH secretion in controlled research settings.
Combined Effects: Research may explore the interaction of CJC-1295 and Ipamorelin on GH signaling pathways in experimental models.
Product Specifications
Purity: ≥98% (verified by HPLC, Certificate of Analysis included).
Form: Lyophilized powder for reconstitution in laboratory-grade solvents.
Storage: Store at -20°C in a dry, controlled environment to ensure stability for research use.
Packaging: Supplied in sterile vials for laboratory applications.
Important Notes
Research Use Only: CJC-1295 and Ipamorelin are strictly for laboratory research by qualified professionals and are not intended for human or animal consumption, diagnostic, or therapeutic purposes. Non-research use violates federal regulations under Sections 503A/503B of the FD&C Act.
Researcher Verification: Orders require confirmation of affiliation with a research institution, academic laboratory, or biotechnology firm to comply with research-use-only (RUO) restrictions.
Safety: Handle according to established laboratory safety protocols. These products have not been evaluated for human safety or efficacy by the FDA.
Ordering Information
Available exclusively for research institutions, academic laboratories, and biotechnology firms.
Each order includes a Certificate of Analysis from an FDA-registered manufacturer to confirm quality for research purposes.
Disclaimer
CJC-1295 and Ipamorelin are provided solely for scientific research and are not FDA-approved for human consumption, medical use, or distribution outside controlled research settings. Any use beyond laboratory research is prohibited and may result in enforcement actions under federal law. Customers must ensure compliance with all applicable regulations, including FDA restrictions on peptide compounding and use. For FDA-approved alternatives for growth hormone-related therapies, consult a healthcare professional.